Market news

Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer ManagementPITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / (NASDAQ:MEDS) ("DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics Corporation ("Helomics") from Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company

Axe Compute (AGPU) sold its AI cancer diagnostics laboratory business called Helomics to DataMEDS AI

Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy...

Investment creates the world’s first Strategic Compute Reserve  Strategy complements Predictive Oncology’s AI/ML-driven drug discovery and development...

Axe Compute's expanding pipeline of Nvidia Blackwell AI projects has fueled optimism, but weak financial results and execution risks remain key concerns.

Axe Compute (AGPU) shares were up nearly 20% in Monday's premarket activity after the company said i